Bain Capital

News, insights, analysis and data

← Back to Bain Capital profile

Bain Capital related stories

All articles and analysis

  • Advent and Bain Capital to acquire Ratepay
    Iris Dorbian- 5 April 2017

    Advent International and Bain Capital Private Equity have agreed to acquire Ratepay GmbH, the German online payment services arm of the Otto Group. No financial terms were disclosed. Advent and Bain Capital are planning to merge RatePay with Concardis, a company both private equity firms acquired earlier this year.

  • China's Creat makes 1.2 billion euro bid for German blood plasma firm: Reuters
    Reuters News- 31 March 2017

    Chinese investor Creat Group Corp has offered to buy German blood plasma products maker Biotest (BIOG.DE) for about 1.2 billion euros ($1.3 billion) including debt following its purchase last year of British peer Bio Products Laboratory, Reuters reported.

  • Making sense of AI
    Mark Boslet- 30 March 2017
  • Bain makes $315m partial exit from Skylark
    Carmela Mendoza- 30 March 2017

    The firm has offloaded a third of its remaining stake in the Japanese restaurant chain for $315m.

  • Bain Capital walks away from Resilux deal after German anti-trust ruling: Reuters
    Reuters News- 28 March 2017

    Bain Capital Private Equity has decided not to proceed with the acquisition of Belgian packaging company Resilux (RESI.BR) due to an anti-trust ruling in Germany, Reuters reported.

  • Sealed Air to sell Diversey Care, other units, to Bain Capital in $3.2 bln deal
    Luisa Beltran- 27 March 2017

    Sealed Air Corp said March 27 that it agreed to sell its Diversey Care division and the food hygiene and cleaning business within its Food Care division to Bain Capital Private Equity. The deal is valued at about $3.2 billion. The combined company, called New Diversey, will be a hygiene and cleaning solutions company that will employ approximately 8,600 people globally.

  • Advent pulls bid for Pfizer's Brazil venture: Reuters
    Reuters News- 23 March 2017

    U.S. private equity firm Advent International Corp has withdrawn from a bidding process to acquire Pfizer Inc's Brazilian generic drugs joint venture, leaving rival Bain Capital LP as the only contender for the company, Reuters reported.

  • Bain Capital's Canada Goose wraps up IPO, raises $390 mln
    Kirk Falconer- 22 March 2017

    Canada Goose Holdings Inc (TSX, NYSE: GOOS), a portfolio company of Bain Capital, has closed its initial public offering in Canada and the United States. Canada Goose raised about $390 million in gross proceeds, which includes the full exercise of an over-allotment purchase option granted to underwriters. Announced earlier this year /canada/2017/3/3439704/ the IPO included a secondary sale by Bain. With its close, the U.S. private equity firm remains the company's majority shareholder. Toronto-based Canada Goose is a designer and maker of luxury outdoor apparel. The public sale reportedly valued it /canada/2017/3/canada-gooses-shares-jump-40-pct-in-stock-market-debut-reuters/ at about $1.8 billion.

  • Buyout funds line up bids for The Body Shop amid pricing challenges, say sources: Reuters
    Reuters News- 20 March 2017

    L'Oreal's (OREP.PA) sale of British retailer The Body Shop has drawn interest from a series of private equity investors who are lining up indicative bids ahead of a mid-April deadline, sources familiar with the matter said on Monday.

  • Unilever prepares 6 billion pound sale of food brands: Reuters
    Reuters News- 20 March 2017

    Unilever (ULVR.L) (UNc.AS) is preparing a 6 billion pound ($7.44 billion) sale of some of its food brands, British newspapers reported on Saturday.